Phase 1 Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women
Recent studies have shown that inhibition of Aquaporine-9 channels may ameliorate the bone degradation process. Pro-bone is an AQ - 9 channels inhibitor. This study is design to evaluate the safety of Pro-bone.
100 Clinical Results associated with OsteoBuild Ltd.
0 Patents (Medical) associated with OsteoBuild Ltd.
100 Deals associated with OsteoBuild Ltd.
100 Translational Medicine associated with OsteoBuild Ltd.